Relaro Medical Trials is driven by a strong, experienced team dedicated to high standards and collaboration in clinical research. With a foundation of repeat business and trusted partnerships, we work closely with Sponsors, aligning efforts to ensure that each study is conducted smoothly and with integrity. Our approach is centered on accurate data collection and patient-focused practices, ensuring compliance and transparency at every phase. Our goal is to contribute meaningfully to the success of each trial, bringing consistency, care, and expertise to every partnership.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 12655 N. Central Expy,
- Phone
- +1 469 730 3282
- st****@****cal.com
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- relaromedical.com
- Keywords
- Psychiatric research, Internal medicine research, Psychiatric clinical trial ratings, Excellent patient selection and retention.
- HQ
- Dallas, TX
Relaro Medical Trials Questions
Relaro Medical Trials's helpline number is +1 469 730 3282
Relaro Medical Trials's website is relaromedical.com
Relaro Medical Trials's LinkedIn profile is https://www.linkedin.com/company/relaro-medical-trials
Relaro Medical Trials has
16 employees.
View email and phone details for 16
employees at Relaro Medical Trials.
Relaro Medical Trials's industry is
Research Services
Relaro Medical Trials's top competitors are
Mary Crowley Cancer Research,
Baylor Scott & White Health,
Dfw Clinical Research,
Cedar Health Research,
Pillar Clinical Research, Llc,
Metroplex Clinical Research Center,
Alliance Clinical Network,
Parexel,
Velocity Clinical Research, Inc.,
Dfw Clinical Trials.
Relaro Medical Trials's support email address is study@relaromedical.com
Relaro Medical Trials's categories are Research Services
Relaro Medical Trials's founding year is 2013
